Cargando…
Rational design and synthesis of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazole derivatives as inhibitors targeting FMS-like tyrosine kinase 3 (FLT3) and its mutants
Fms-like tyrosine kinase 3 (FLT3) has been verified as a therapeutic target for acute myeloid leukaemia (AML). In this study, we report a series of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazol-5-yl benzamide and phenyl urea derivatives as potent FLT3 inhibitors based on the structural optimisation of pre...
Autores principales: | Im, Daseul, Jun, Joonhong, Baek, Jihyun, Kim, Haejin, Kang, Dahyun, Bae, Hyunah, Cho, Hyunwook, Hah, Jung-Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788362/ https://www.ncbi.nlm.nih.gov/pubmed/35067150 http://dx.doi.org/10.1080/14756366.2021.2020772 |
Ejemplares similares
-
Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-N-(2-aryl-1H-benzo[d]imidazo-5-yl)isoxazole-4-carboxamide analogues as selective FLT3 inhibitors
por: Im, Daseul, et al.
Publicado: (2019) -
Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1H)-Carboxamide as a Novel JNK Inhibitor
por: Jang, Miyoung, et al.
Publicado: (2020) -
Design and Synthesis of a Novel PLK1 Inhibitor Scaffold Using a Hybridized 3D-QSAR Model
por: Oh, Youri, et al.
Publicado: (2021) -
Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives as a novel selective inhibitor scaffold of JNK3
por: Oh, Youri, et al.
Publicado: (2019) -
3-(4-Pyridyl)-4,5-dihydro-1H-benzo[g]indazole
por: Xiao, Xin, et al.
Publicado: (2008)